Catherine Alix-Panabières, Professor of Oncology at the Faculty of Medicine of the University of Montpellier, shared a post on LinkedIn:
“Excited to share a glimpse of our work featured at FUTURAPOLIS, an event organized by Le Point magazine!
In this video, part of our Liquid Biopsy LCCRH Lab – Laboratoire Cellules Circulantes Rares Humaines’s activity on Liquid Biopsy is highlighted — an innovative and translational research approach aiming to better manage cancer patients through Precision Medicine.
I had the pleasure of being interviewed by the excellent Journalist Anne Jeanblanc, where I explained how we are developing and applying Liquid Biopsy technologies to monitor tumors in real-time to guide personalized treatment decisions, ultimately improving patient outcomes at CHU de Montpellier (SUB).
My interview appears from 6’29 to 13’54 in the video.
Watch it here.
A big thank you to FUTURAPOLIS and Le Point teams for showcasing our vision and research, and to everyone in the lab contributing to these exciting advances in cancer care.”
More posts featuring Catherine Alix-Panabières on OncoDaily.